Literature DB >> 10342278

Regional blood flow distribution from the proximal arterial cannula during veno-arterial extracorporeal membrane oxygenation in neonatal dog.

T Kamimura1, H Sakamoto, K Misumi.   

Abstract

Extracorporeal membrane oxygenation (ECMO) is frequently used for treatment of patients with severe hypoxemia due to life-threatening respiratory failure. Due to this hypoxemia, the myocardium of these patients is insufficiently provided with oxygen, and consequently their cardiac function commonly deteriorates. But veno-arterial (V-A) ECMO provides oxygenated blood to the coronary arteries from ECMO circuit insufficiently. To increase the coronary blood flow distributed from ECMO, we placed the arterial cannula 1 cm above the aortic valve and evaluated the regional blood from the proximal arterial cannula in comparison with the distal cannula. Eight neonatal dogs weighting 1.8-2.5 kg were supported by V-A ECMO. The regional blood flow from the arterial cannula was measured by injection of colored microspheres into ECMO circuit. The site of the arterial cannula was changed under fluoroscopy. The bypass flow was maintained at either 50 or 100 ml/min/kg. We found that the coronary blood flow distributed from the proximal arterial cannula was significantly higher than that from the distal cannula. The proximal arterial cannula appears necessary to provide sufficient oxygenated blood to the coronary circulation during V-A ECMO. Therefore, it is expected that the increased cardiac function may improved, and that the survival rate of the patients with retarded cardiac function due to severe hypoxemia may increase by proximal placement of the arterial cannula during V-A ECMO.

Entities:  

Mesh:

Year:  1999        PMID: 10342278     DOI: 10.1292/jvms.61.311

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  7 in total

Review 1.  Hemodynamic adaptation of heart failure to percutaneous venoarterial extracorporeal circulatory supports.

Authors:  P Hála; O Kittnar
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

2.  Regional variation in arterial saturation and oxygen delivery during venoarterial extracorporeal membrane oxygenation.

Authors:  Dimitrios V Avgerinos; William DeBois; Lilia Voevidko; Arash Salemi
Journal:  J Extra Corpor Technol       Date:  2013-09

3.  Regional perfusion during venoarterial extracorporeal membrane oxygenation: a case report and educational modules on the concept of dual circulations.

Authors:  Cory M Alwardt; Bhavesh M Patel; Amelia Lowell; Jeff Dobberpuhl; Jeffrey B Riley; Patrick A DeValeria
Journal:  J Extra Corpor Technol       Date:  2013-09

4.  Renal hemodynamics by return cannular position of extracorporeal membrane oxygenation in swine.

Authors:  Hee Jung Kim; Seong Cheol Jeong; Jae Seung Jung; In Seup Kim; Choon-Hak Lim; Ho Sung Son
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

5.  Coronary versus carotid blood flow and coronary perfusion pressure in a pig model of prolonged cardiac arrest treated by different modes of venoarterial ECMO and intraaortic balloon counterpulsation.

Authors:  Jan Bělohlávek; Mikuláš Mlček; Michal Huptych; Tomáš Svoboda; Stěpán Havránek; Petr Ošt'ádal; Tomáš Bouček; Tomáš Kovárník; František Mlejnský; Vratislav Mrázek; Marek Bělohlávek; Michael Aschermann; Aleš Linhart; Otomar Kittnar
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

6.  The Effect of Additional Stepwise Venous Inflow on Differential Hypoxia of Veno-Arterial Extracorporeal Membrane Oxygenation.

Authors:  Jin Gu Lee; Namo Kim; Kyoung Shik Narm; Jee Won Suh; Jisung Hwang; Hyo Chae Paik; Young Chul Yoo
Journal:  ASAIO J       Date:  2020-07       Impact factor: 3.826

7.  Watershed phenomena during extracorporeal life support and their clinical impact: a systematic in vitro investigation.

Authors:  Johannes Gehron; Maximilian Schuster; Florian Rindler; Markus Bongert; Andreas Böning; Gabriele Krombach; Martin Fiebich; Philippe Grieshaber
Journal:  ESC Heart Fail       Date:  2020-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.